A novel bioreactor for the stable growth of Ureaplasma parvum and Ureaplasma urealyticum

Derek Fleming1, Melissa Karau1, Robin Patel2

  • 1Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States of America.

Insights

Culturing Ureaplasma species like Ureaplasma parvum and Ureaplasma urealyticum is difficult. A new bioreactor enables stable, high-titer liquid cultures for these challenging microorganisms.

Area of Science:

  • Microbiology
  • Biotechnology

Background:

  • Ureaplasma species are frequently isolated from human urogenital tracts.
  • Culturing Ureaplasma parvum and Ureaplasma urealyticum poses significant challenges due to their fastidious growth requirements.

Purpose of the Study:

  • To develop and validate a novel bioreactor system for the stable, high-titer cultivation of Ureaplasma species.
  • To overcome the limitations of traditional culture methods for Ureaplasma.

Main Methods:

  • Design and implementation of a novel bioreactor tailored for Ureaplasma growth.
  • Optimization of culture conditions within the bioreactor.
  • Assessment of culture stability and Ureaplasma titer over time.

Main Results:

  • The novel bioreactor successfully supported the growth of Ureaplasma species.
  • High-titer liquid cultures were achieved and maintained in a stable manner.
  • Demonstrated superiority over conventional culture techniques.

Conclusions:

  • The developed bioreactor offers a robust solution for culturing Ureaplasma species.
  • Facilitates research and diagnostics requiring large quantities of viable Ureaplasma.
  • Paves the way for improved understanding and management of Ureaplasma-associated conditions.

Related Concept Videos

Bioreactor Design and Operational System01:29

Bioreactor Design and Operational System

Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...
Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...